HomeInsightsStock Comparison

Aarti Drugs Ltd vs Torrent Pharmaceuticals Ltd Stock Comparison

Aarti Drugs Ltd vs Torrent Pharmaceuticals Ltd Stock Comparison

Last Updated on: Aug 18, 2025

Key Highlights

  • The Latest Trading Price of Aarti Drugs Ltd is ₹ 503.9 as of 18 Aug 15:30.
  • The P/E Ratio of Aarti Drugs Ltd changed from 8.3 on March 2020 to 0 on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Torrent Pharmaceuticals Ltd changed from 32.6 on March 2020 to 57.3 on March 2025 . This represents a CAGR of 9.86% over 6 years.
  • The Market Cap of Aarti Drugs Ltd changed from ₹ 1178 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Torrent Pharmaceuticals Ltd changed from ₹ 33361 crore on March 2020 to ₹ 109468 crore on March 2025 . This represents a CAGR of 21.90% over 6 years.
  • The revenue of Aarti Drugs Ltd for the Jun '25 is ₹ 590.82 crore as compare to the Mar '25 revenue of ₹ 678.63 crore. This represent the decline of -12.94% The revenue of Torrent Pharmaceuticals Ltd for the Jun '25 is ₹ 3141 crore as compare to the Mar '25 revenue of ₹ 2941 crore. This represent the growth of 6.8%.
  • The ebitda of Aarti Drugs Ltd for the Jun '25 is ₹ 74.39 crore as compare to the Mar '25 ebitda of ₹ 95.2 crore. This represent the decline of -21.86% The ebitda of Torrent Pharmaceuticals Ltd for the Jun '25 is ₹ 995 crore as compare to the Mar '25 ebitda of ₹ 922 crore. This represent the growth of 7.92%.
  • The net profit of Aarti Drugs Ltd changed from ₹ 47.97 crore to ₹ 53.97 crore over 9 quarters. This represents a CAGR of 5.38% The net profit of Torrent Pharmaceuticals Ltd changed from ₹ 378 crore to ₹ 548 crore over 9 quarters. This represents a CAGR of 17.95% .
  • The Dividend Payout of Aarti Drugs Ltd changed from 3.43 % on March 2020 to 0 % on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe Dividend Payout of Torrent Pharmaceuticals Ltd changed from 57.71 % on March 2020 to 10.76 % on March 2025 . This represents a CAGR of -24.42% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Aarti Drugs Ltd

  • Aarti Drugs Limited (ADL), incorporated in September, 1984 is a prominent manufacturer of APIs, Pharma Intermediates, and Specialty Chemicals.
  • The Company operates as part of the Aarti Group, a conglomerate with a net worth of USD 900 million.
  • With over 50 compounds for Antibiotics, Anti Protozoal, Anti-Inflammatory, Anti-diabetic, Anti Fungal and Cardioprotectant therapeutic segments, the Company has emerged as market leader in APIs.
  • It has a wholly-owned subsidiary called Pinnacle Life Science Private Limited which operates in the field of manufacturing formulations. The Company has two R&D divisions, one in Tarapur and the other in Turbhe, Maharashtra.
  • It has 3 subsidiaries, namely, Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited and Pinnacle Chile SpA (foreign subsidiary).

About Torrent Pharmaceuticals Ltd

  • Torrent Pharmaceuticals Limited is a leading player in the Indian pharmaceutical sector, concentrating on the chronic and sub-chronic therapeutic segments.
  • The Company has established itself as a leader in developing niche pharmaceutical solutions through its patient-centric innovation.
  • The Company is a dominant player in the therapeutic areas of Cardiovascular (CV), Central Nervous System (CNS), Vitamins and Nutrients (VMN), Gastro-Intestinal (GI) and Anti-Diabetes (AD) therapies in India.
  • It has a strong international presence across more than 40 countries with operations in regulated and emerging markets, such as the US, Europe, Germany, Brazil and Rest of the World. The Company operates through its wholly-owned subsidiaries spread across 15 countries with major setups in the US, Germany and Brazil.

Aarti Drugs Ltd News Hub

News

Aarti Drugs rises after Q1 PAT jumps 62% YoY to Rs 54 cr

Profit before tax (PBT) rose 16.2% YoY to Rs 51.11 crore in Q1 June 2025. EBITDA jumped 12...

Read more

21 Jul 2025 14:06

News

Aarti Drugs to convene board meeting

Aarti Drugs will hold a meeting of the Board of Directors of the Company on 18 July 2025. ...

Read more

16 Jul 2025 10:24

News

Aarti Drugs to convene board meeting

Aarti Drugs will hold a meeting of the Board of Directors of the Company on 6 May 2025. Po...

Read more

30 Apr 2025 11:38

News

Aarti Drugs receives affirmation in credit ratings from ICRA

Aarti Drugs has received reaffirmation in credit rating at ICRA AA-; Stable/ ICRA A1+ for ...

Read more

31 Jan 2025 19:10

News

Aarti Drugs gains as PAT rises to Rs 37 cr in Q3; declares dividend of Re 1/sh

Revenue from operations declined 6.44% to Rs 568.50 crore in third quarter of FY25 as comp...

Read more

30 Jan 2025 12:14

News

Board of Aarti Drugs recommends Interim Dividend

Aarti Drugs announced that the Board of Directors of the Company at its meeting held on 29...

Read more

29 Jan 2025 17:03

Torrent Pharmaceuticals Ltd News Hub

News

Torrent Pharma's Vizag facility clears USFDA inspection with zero observations

According to an exchange filing, the inspection was conducted from 28 July to 1 August 202...

Read more

04 Aug 2025 09:44

News

Torrent Pharma gains as Q1 earnings impress; foreign broker hikes target

The pharma major reported a net profit of Rs 548 crore, marking a 20% year-on-year increas...

Read more

29 Jul 2025 10:36

News

Torrent Pharmaceuticals Ltd gains for third straight session

Torrent Pharmaceuticals Ltd is up for a third straight session today. The stock is quoting...

Read more

29 Jul 2025 13:05

News

Board of Torrent Pharmaceuticals approves issuance of NCDs/ bonds

The Board of Torrent Pharmaceuticals at its meeting held on 28 July 2025 has approved the ...

Read more

28 Jul 2025 16:32

News

Torrent Pharmaceuticals to hold board meeting

Torrent Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28...

Read more

22 Jul 2025 10:21

News

Torrent Pharmaceuticals Ltd gains for fifth session

Torrent Pharmaceuticals Ltd is up for a fifth straight session in a row. The stock is quot...

Read more

18 Jul 2025 13:00

SWOT Analysis Of Torrent Pharmaceuticals Ltd

Strength

4

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Aarti Drugs Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Torrent Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Aarti Drugs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Aarti Drugs Ltd and Torrent Pharmaceuticals Ltd

Which company has a larger market capitalization, Aarti Drugs Ltd or Torrent Pharmaceuticals Ltd?

Market cap of Aarti Drugs Ltd is 4,632 Cr while Market cap of Torrent Pharmaceuticals Ltd is 123,633 Cr

What are the key factors driving the stock performance of Aarti Drugs Ltd and Torrent Pharmaceuticals Ltd?

The stock performance of Aarti Drugs Ltd and Torrent Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aarti Drugs Ltd and Torrent Pharmaceuticals Ltd?

As of August 18, 2025, the Aarti Drugs Ltd stock price is INR ₹503.9. On the other hand, Torrent Pharmaceuticals Ltd stock price is INR ₹3653.15.

How do dividend payouts of Aarti Drugs Ltd and Torrent Pharmaceuticals Ltd compare?

To compare the dividend payouts of Aarti Drugs Ltd and Torrent Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions